Compare CCB & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCB | PRGO |
|---|---|---|
| Founded | 1997 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2018 | 2013 |
| Metric | CCB | PRGO |
|---|---|---|
| Price | $82.29 | $11.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $126.67 | $19.33 |
| AVG Volume (30 Days) | 113.2K | ★ 2.9M |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 9.92% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.06 | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | $96.61 | N/A |
| Revenue Next Year | $22.66 | $1.02 |
| P/E Ratio | $27.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $70.72 | $9.23 |
| 52 Week High | $120.05 | $28.44 |
| Indicator | CCB | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 54.38 | 58.88 |
| Support Level | $73.44 | $9.24 |
| Resistance Level | $85.88 | $15.08 |
| Average True Range (ATR) | 2.21 | 0.45 |
| MACD | 0.32 | 0.15 |
| Stochastic Oscillator | 58.03 | 80.63 |
Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.